Gyanu Lamichhane of Johns Hopkins University in the U.S. will develop a novel vaccine for TB based on existing BCG vaccines modified to express a gene that is specific to latent TB in order to generate a robust immune response to a latent infection.
Grant ID
OPP53213
Show on Hub
On
Show on Spoke
On
Follow-on Funding
Off
Lead Funding Organization
Initiatives
Principal Investigator
Award Manager
Individual Funder Information
Funding Organization
Funding Amount (in original currency)
100000.00
Funding Currency
USD
Funding Amount (in USD)
100000.00
Project Type
Project Primary Sector
Project Subsector
Funding Date Range
-
Funding Total (In US dollars)
100000.00
Co-Funded
False